Researchers at the University of Pittsburgh created a new model to study a mosquito-borne virus, which they said could be helpful to the public health response in future pandemics.

The study, published in the PLOS Pathogens earlier this month, looks at the adverse effects of Rift Valley Fever Virus, known as RVFV.

It uses a specially bred, genetically diverse group of mice to study the physical effects of RVFV on liver and brain disease. The model offers a new way for scientists to study viruses as researchers prepare for another pandemic.

RVFV is a virus that is commonly found in livestock like cows, sheep, goats and camels in Africa and the Middle East, according to the Centers for Disease Control and Prevention. Researchers said the virus is frequently spread via mosquito and is similar to other mosquito-transmitted diseases like the Zika virus.

Advertise with us

“It can be transmitted by mosquitoes prevalent all over the globe,” Dr. Anita McElroy, a co-author of the study and an assistant professor at the University of Pittsburgh, said. “So that’s the real concern for this virus. It has the potential to spread to other parts of the world, including the United States, because we have mosquitoes capable of transmitting the virus here.”

Because of the global presence of its vectors and hosts, the World Health Organization and the National Institute of Allergy and Infectious Diseases have designated RVFV a priority for research.

Using a special mouse population that serves as an experimental tool for genetic researchers, McElroy said, the scientists created a blueprint for research to test RVFV vaccines and other antiviral drugs, study how the virus attacks the brain, and decipher which genes lead to more harmful long-term outcomes in RVFV infections.

Most people who contract RVFV will display mild symptoms like back pain, fever, dizziness and weakness, but in about 10% of people, the virus can cause more harmful long-term symptoms like liver failure and brain and eye disease, according to the CDC. McElroy said there is uncertainty surrounding why the long-term effects appear in certain patients and not in others, and she said the model could help clarify the genetic differences.

The CDC has reported more than a dozen RVFV outbreaks since 2000. However, none of those outbreaks occurred in the United States.

Advertise with us

What makes the new study unique, McElroy explained, is that it uses a genetically diverse pool of mice, which include dozens of sequenced, varied mice genomes to study the effects of the virus on the mouse bodies.

In the past, scientists only used one strain of mice to conduct research. Since the mice shared similar genomes, the virus had similar effects across all the test subjects, and the results of studies on mice were misrepresentative, McElroy said.

She said the genetically diverse mice, known as Collaborative Cross mice, are more reliable for their research because they represent the diverse genes and adverse effects humans can display.

Scientists can also use them in studying topics such as salmonella, metabolic diseases, staph infections, vaccines or lead poisoning.

For this study, researchers injected the foot of a mouse with RVFV. They could monitor the effects of the virus on the mouse and then “use that information to help us figure out exactly which genes are controlling these outcomes,” McElroy said.

Advertise with us

David Threadgill, a professor of genetics at the University of Texas A&M and an expert in Collaborative Cross mice, said RVFV, like many other diseases, produces various effects on each person, depending on the subject.

He added that scientists are frequently unsure of the reasoning behind the body’s varied responses to disease, and the new model could help close the gap.

“It’s not until you use these heterogeneous models where you can start seeing the full spectrum that you see in humans and allows people to understand the mechanism of those but also, potential therapeutic interventions that would prevent some of the more severe consequences of the infection,” he said.

There has been an RVFV vaccine available for livestock for decades, “but alone, this tool has not been able to stop RVFV outbreaks,” said Keli Gerken, a post-doctoral researcher at Stanford University who studies RVFV.

Amy Hartman, an associate professor of infectious diseases at the University of Pittsburgh, said that RVFV is only getting more transmissible due to climate change. She emphasized that as climate change continues to expand the scope and range that RVFV-carrying mosquitoes can travel, then the spread of the virus will also increase.

Advertise with us

“All these mosquito-transmitted viruses can emerge in new locations, and climate change has made the occurrence of mosquito-transmitted outbreaks more frequent,” she said.

Martin Ferris, a co-author of the study and an associate professor of genetics at the University of North Carolina at Chapel Hill, said that as the world becomes more interconnected and people continue to travel internationally, the chances of a virus turning into a pandemic also increase.

“These are still diseases that affect huge populations in the world. So if we can understand them, we can help alleviate the disease burden to those parts of the world,” he added.

Ferris emphasized that even if RVFV is not common in the United States, the threat of its spread still exists, so scientists should still prepare and study the virus to find solutions.

“Rift Valley Fever Virus may not be endemic in the U.S., but if we start understanding differences in human hosts that are prepositioned to be sick when they travel or are exposed to these things we already have a leg up in thinking about how we might be ready to treat them, or communicating with people their risks,” he said.

Nick Pasion: npasion@post-gazette.com or on Twitter @nicholaspasion.